Clinical Trials Browser

Waldenstrom Macroglobulinemia × carfilzomib × 90 days × Clear all

NCT04263480 2026-05-12

CZAR-1

Phase 2 Active not recruiting

Waldenstrom Macroglobulinemia, Neoplasms

NCT01813227 2026-04-03

A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531

Phase 2 Completed

7 enrolled 10 charts

Waldenstrom Macroglobulinemia